Anada made $2 billion in revenue in the third quarter
On October 22, Anada announced its third quarterly report for 2022. In the first three quarters, the company achieved revenue of 1.989 billion yuan, an increase of 36.93% year-on-year; The net profit returned to mother was 201 million yuan, up 56.06% year-on-year. In the third quarter, the company achieved revenue of 634 million yuan, an increase of 16.91% year-on-year; The net profit returned to mother was 73.3649 million yuan, an increase of 71.20% year-on-year. The increase in revenue was mainly caused by the increase in the price of the company's products and the increase in the sales volume of its subsidiaries' products during the period.
In the first three quarters of this year, Anada's operating cost was 1.574 billion yuan, up 30.8 percent year-on-year, lower than the 36.9 percent year-on-year growth in operating revenue, leading to a 3.7 percent increase in gross profit margin, the annual report showed. The period expense ratio was 4.8%, down 0.5 percentage points from last year. Operating cash flow surged 1583.3% to 233 million yuan.
2026-08-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Behind Arkema’s ¥430 Million Claim: A Patent War Over Acrylic Acid Is Tearing Off the “Technical Fig Leaf” of China’s Chemical Giants
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
EU Clears Carlyle's Acquisition of BASF's Coatings Business, but Demands Divestment of Nouryon's Polysulfide Assets: What Are the Underlying Risks?
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Another Major Coating Manufacturer Acquired by a Central SOE: BNBM Acquires SUNROAD Group for Over RMB 300 Million, Locks in Three-Year Performance Pledge
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
LG Chem Enters Semiconductor Stripper Market for the First Time, Cutting Process Time by 50%
-
EFSA Evaluates Safety of Triacylglycerol Lipase from Ruminant Pregastric Tissue
-
EFSA Unable to Conclude on Full-Scope Safety of Genetically Modified Oilseed Rape LBFLFK
Recommend Reading
-
Zimbabwe Blueberries Position for Growth Following China Market Access and Zero-Tariff Policy
-
Canada Proposes Revised Maximum Residue Limits for Pyrethrins and Penthiopyrad
-
APVMA Suspends Dimethoate Use on Select Berries Amid Updated Exposure Assessment
-
The GLP-1 Sweet Shot in India’s Diabetic Gut
-
EFSA Publishes Peer Review Conclusions on Phenmedipham Herbicide Assessment
-
Widening Downward Spread, Weekly Decline in n-Butanol Exceeds 5%
-
U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End
-
This Week's Isopropanol Market Prices First Increased Then Decreased in China (5.18-5.22)
-
Cost Support Boosts Acrylic Acid, High-level Supply and Demand Stalemate Leads to Sideways Movement
-
Premium Global Chemical Sourcing Requests (2-3Jun, 2026)